Sponsor

Université de Sherbrooke

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Université de Sherbrooke appears in 100 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials100
Recruiting shown12
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in AsthmaNCT07309614 · lead sponsor · 2026-01-29
RECRUITING
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold-induced Shivering ThermogenesisNCT07573917 · lead sponsor · 2025-09-24
RECRUITING
Recovery With Exogenous Ketones and AntipsychoticsNCT07122531 · lead sponsor · 2025-08-26
RECRUITING
Triple Negative Breast Cancer and Celecoxib. Pilot StudyNCT07104266 · lead sponsor · 2025-08-04
RECRUITING
Impact of Resistance Training Intensity on Blood PressureNCT06845514 · lead sponsor · 2025-07-08
RECRUITING
Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer TreatmentNCT06911970 · lead sponsor · 2025-04-01
RECRUITING
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and AdultsNCT06981169 · lead sponsor · 2025-03-24
RECRUITING
Predicting Breast Cancer With the BRAVE SystemNCT06498388 · lead sponsor · 2025-01-28
RECRUITING
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine LesionNCT05451251 · lead sponsor · 2024-10-15
RECRUITING
Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric SurgeryNCT05934409 · lead sponsor · 2023-11-01
RECRUITING
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle FactorsNCT05123963 · lead sponsor · 2021-09-15
RECRUITING
Healthy for my Baby- RCT of a Lifestyle Intervention for Overweight Women in PreconceptionNCT04242069 · lead sponsor · 2021-06-18
RECRUITING
How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the LiverNCT07133854 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Alleviating Dyspnea With Non-Invasive NeuromodulationNCT06985628 · lead sponsor · 2024-11-18
COMPLETED
The ATP Project (Antipsychotic-TEP-Psychosis)NCT06651112 · lead sponsor · 2024-11-01
NOT_YET_RECRUITING
Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational InvestigationNCT07011394 · lead sponsor · 2024-04-09
ACTIVE_NOT_RECRUITING
Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.NCT06294015 · lead sponsor · 2024-03-01
UNKNOWN
Obesity-fertility Cohort Study: Protocol for the Assessment of Children Aged 6-12 Years and Their MothersNCT06402825 · lead sponsor · 2023-11-13
COMPLETED
Telerehabilitation for Dysautonomia in Parkinson's DiseaseNCT06017232 · lead sponsor · 2023-06-13
COMPLETED
HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)NCT05636995 · lead sponsor · 2023-01-10
ACTIVE_NOT_RECRUITING
Acute Oral Ketones or Carbohydrate Supplement Modify Heart Function in Heart Failure?NCT05651529 · lead sponsor · 2022-12-16
COMPLETED
Feasibility Study of a Community Pilot Project for the Prevention of Alzheimer's Disease: the KetoHome Study.NCT05642052 · lead sponsor · 2022-11-28
COMPLETED
Diagnostic and Translational Values of Point-of-care Blood Eosinophils and Exhaled Nitric Oxide (FeNO) in People Referred by Primary Care for Suspected AsthmaNCT05992519 · lead sponsor · 2022-11-07
COMPLETED
Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma AttacksNCT05870215 · lead sponsor · 2022-09-01
COMPLETED
Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)NCT05553184 · lead sponsor · 2022-07-05
COMPLETED
Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders PopulationNCT04322461 · lead sponsor · 2022-05-01
COMPLETED
High-intensity Interval Training Prescriptions to Reduce the Risk of Complications Linked to Type 2 Diabetes: the Role of Interval Length on Clinical Benefits and on Physiological MechanismsNCT04986345 · lead sponsor · 2021-10-04
UNKNOWN
Brown Adipose Tissue Metabolism in Type 2 DiabetesNCT05092945 · lead sponsor · 2021-05-18
COMPLETED
Activation of Brown Adipose Tissue Metabolism Using MirabegronNCT04823442 · lead sponsor · 2021-01-21
COMPLETED
Optimizing Maintenance for Patients with COPD Via a Web Platform - Case StudyNCT04284865 · lead sponsor · 2020-11-01
COMPLETED
BRain Energy Activation With Ketones to Prevent Alzheimer's DiseaseNCT04466735 · lead sponsor · 2020-10-15
COMPLETED
Tai Chi Intervention by TelerehabilitationNCT03985631 · lead sponsor · 2020-01-22
COMPLETED
Fluoroscopy Reduction or Elimination in CIED ImplantsNCT04919733 · lead sponsor · 2020-01-03
UNKNOWN
3TMPO (Triple-Tracer Strategy Against Metastatic Prostate CancerNCT04000776 · lead sponsor · 2019-12-16
COMPLETED
Fit-for-Fertility Multicenter Randomized Controlled TrialNCT03908099 · lead sponsor · 2019-04-03
ACTIVE_NOT_RECRUITING
Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF)NCT03298009 · lead sponsor · 2018-05-01
WITHDRAWN
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive SymptomsNCT03514355 · lead sponsor · 2017-09-04
COMPLETED
Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)NCT03188835 · lead sponsor · 2017-05-23
COMPLETED
Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)NCT02808182 · lead sponsor · 2017-01-17
COMPLETED
Pharmacological Activation of Brown Adipose Tissue MetabolismNCT02811289 · lead sponsor · 2016-08-05
COMPLETED
Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionNCT02796560 · lead sponsor · 2016-07-01
COMPLETED
Patient-Centred Innovations for Persons With Multimorbidity - QuebecNCT02789800 · lead sponsor · 2016-04-22
COMPLETED
Medium Chain Triglycerides and Brain Metabolism in Alzheimer's DiseaseNCT02709356 · lead sponsor · 2015-10-01
COMPLETED
Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without PrediabetesNCT02678390 · lead sponsor · 2015-09-01
COMPLETED
Postprandial Metabolism After Bariatric Surgery in Type 2 DiabetesNCT02815943 · lead sponsor · 2015-08-01
COMPLETED
Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive PregnancyNCT02523781 · lead sponsor · 2015-06-01
COMPLETED
Impact of a Regional Program Agir Sur Sa SantENCT02478853 · lead sponsor · 2015-03-01
ACTIVE_NOT_RECRUITING
Glycemic Objectives of Women With Gestational Diabetes MellitusNCT02478762 · lead sponsor · 2015-03-01
TERMINATED
Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical HypothyroidismNCT02316743 · lead sponsor · 2014-12-01
UNKNOWN
Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes MellitusNCT02290860 · lead sponsor · 2014-12-01
COMPLETED
Diagnosis Test for Gestational Diabetes MellitusNCT02482662 · lead sponsor · 2014-11-01
COMPLETED
Postpartum Screening of Type 2 DiabetesNCT01869608 · lead sponsor · 2014-04-01
COMPLETED
Evaluation of Educational Tools for Pregnant WomenNCT01858324 · lead sponsor · 2014-03-01
COMPLETED
Prebariatric Surgery Physical Exercise Training in TelehealthNCT02083913 · lead sponsor · 2014-02-01
COMPLETED
Gestational Diabetes Mellitus and Neurodevelopment in NewbornsNCT02779452 · lead sponsor · 2013-12-01
COMPLETED
The Retroclavicular Approach for Regional Anesthesia of the Upper Limb in Obese PatientsNCT02086643 · lead sponsor · 2013-12-01
COMPLETED
Healthy Start to Increase Physical Activity and Improve Healthy Eating in Early Childcare CentresNCT02375490 · lead sponsor · 2013-09-01
COMPLETED
Bone Resorption, Osteoclastogenesis and AdalimumabNCT02035800 · lead sponsor · 2013-05-01
UNKNOWN
Etiologies, Investigations and Outcomes of Patients Presenting With HemoptysisNCT02913365 · lead sponsor · 2012-10-01
UNKNOWN
Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century KinshasaNCT02439918 · lead sponsor · 2012-06-01
COMPLETED

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Université de Sherbrooke as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
adalimumab2
niacin2
bisoprolol fumarate1
dupilumab Prefilled Syringe1
fentanyl1
insulin, regular, human1
leuprolide acetate1
mirabegron1
adalimumab RxCUI 327361 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials niacin RxCUI 7393 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials bisoprolol fumarate RxCUI 142146 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dupilumab Prefilled Syringe RxCUI 1876400 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial fentanyl RxCUI 4337 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial insulin, regular, human RxCUI 253182 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial leuprolide acetate RxCUI 203217 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial mirabegron RxCUI 1300786 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial niacin 50 MG Oral Tablet RxCUI 198760 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial vasopressin (USP) RxCUI 11149 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor87
collaborator13
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.